Cargando…
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?
SIMPLE SUMMARY: Due to the rarity of the entity of cholangiocarcinoma, there is a lack of randomized clinical trials which can compared modalities of treatment for unresectable intra-hepatic cholangiocarcinoma (iCC). In this review, we proposed to summarize current evidence regarding all the modalit...
Autores principales: | Bourien, Héloïse, Pircher, Chiara Carlotta, Guiu, Boris, Lamarca, Angela, Valle, Juan W, Niger, Monica, Edeline, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486617/ https://www.ncbi.nlm.nih.gov/pubmed/37686493 http://dx.doi.org/10.3390/cancers15174217 |
Ejemplares similares
-
Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023) -
Patients’ Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life
por: Muzellec, Léa, et al.
Publicado: (2021) -
Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022) -
Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies
por: Gorji, Leva, et al.
Publicado: (2023) -
Locoregional Approaches in Cholangiocarcinoma Treatment
por: Hare, Alexander E., et al.
Publicado: (2022)